APA (7th ed.) Citation

J, M., M, A., TH, C., J, N., CC, T., VL, A., . . . J, A. (2025). Association of nucleoside reverse transcriptase inhibitor use with reduced risk of Alzheimer's disease risk. Alzheimer's & dementia : the journal of the Alzheimer's Association, 21(5), e70180. https://doi.org/10.1002/alz.70180

Chicago Style (17th ed.) Citation

J, Magagnoli, Ambati M, Cummings TH, Nguyen J, Thomas CC, Ambati VL, Sutton SS, Gelfand BD, and Ambati J. "Association of Nucleoside Reverse Transcriptase Inhibitor Use with Reduced Risk of Alzheimer's Disease Risk." Alzheimer's & Dementia : The Journal of the Alzheimer's Association 21, no. 5 (2025): e70180. https://doi.org/10.1002/alz.70180.

MLA (9th ed.) Citation

J, Magagnoli, et al. "Association of Nucleoside Reverse Transcriptase Inhibitor Use with Reduced Risk of Alzheimer's Disease Risk." Alzheimer's & Dementia : The Journal of the Alzheimer's Association, vol. 21, no. 5, 2025, p. e70180, https://doi.org/10.1002/alz.70180.